£107.50

Springer - Peptides and Non Peptides of Oncologic Relevance

Price data last checked 66 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 25 days • 25 data points (No recent data available)

Historical
Generating forecast...
£109.85 £107.27 £107.83 £108.39 £108.96 £109.52 £110.09 28 January 2026 03 February 2026 09 February 2026 15 February 2026 21 February 2026

Price Distribution

Price distribution over 25 days • 2 price levels

Days at Price
Current Price
1 day · current 24 days 0 6 12 18 24 £108 £110 Days at Price

Price Analysis

Most common price: £110 (24 days, 96.0%)

Price range: £108 - £110

Price levels: 2 different prices over 25 days

Description

Explore the complex relationship between endocrine-derived compounds and cancer treatment in this specialized medical text from Springer. This book examines how specific peptides and non-peptide compounds, such as CRH, LHRH, somatostatin, anti-androgens, and aromatase inhibitors, can exert direct anti-neoplastic activity. It also details how these substances can work to strengthen the effectiveness of traditional chemotherapy when treating neuroendocrine and solid tumors. Beyond established treatments, the text introduces a new class of potent GH-releasers, specifically GSHs/Ghrelin, which possess significant endocrine and extra-endocrine actions. For researchers and medical professionals looking for alternatives to traditional chemotherapy, which is often limited by high toxicity and non-selective action on tumoral cells, this book offers a look at more selective approaches to oncology and neuroendocrine research.

Key Features

Covers the direct anti-neoplastic activity of endocrine-derived compounds like CRH, LHRH, and somatostatin.

Discusses how anti-androgens and aromatase inhibitors can potentiate the activity of traditional chemotherapeutic agents.

Provides research on neuroendocrine and solid tumors to aid in clinical and basic research studies.

Introduces the new class of potent GH-releasers and Ghrelin with important endocrine actions.

Offers an alternative perspective to traditional chemotherapy by focusing on more selective therapeutic approaches.

Addresses the limitations of non-selective chemotherapy, such as high toxicity, in tumor cell treatment.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
18 September 2003
Listed Since
09 December 2006

Barcode

No barcode data available

Similar Products You Might Like

Peptides in Oncology III: Somatostatin and LH-RH Analogues: 153 (Recent Results in Cancer Research, 153)
94% match

Peptides in Oncology III: Somatostatin and LH-RH Analogues: 153 (Recent Results in Cancer Research, 153)

Springer

£72.07 01 Mar 2026
Small Molecules for Cancer Treatment
93% match

Small Molecules for Cancer Treatment

Springer

£162.73 06 Feb 2026
Cancer Therapy: Monoclonal Antibodies, Lymphokines New Developments in Surgical Oncology and Chemo- and Hormonal Therapy
92% match

Cancer Therapy: Monoclonal Antibodies, Lymphokines New Developments in Surgical Oncology and Chemo- and Hormonal Therapy

Springer

£78.77 26 Feb 2026
Growth Hormone Secretagogues in Clinical Practice
92% match

Growth Hormone Secretagogues in Clinical Practice

CRC Press

£134.76 12 Jan 2026
Growth Hormone II: Basic and Clinical Aspects (Serono Symposia USA)
92% match

Growth Hormone II: Basic and Clinical Aspects (Serono Symposia USA)

Springer

£76.85 08 Mar 2026
Springer - Therapeutic Resistance to Anti-hormonal Drugs Book
92% match

Springer - Therapeutic Resistance to Anti-hormonal Drugs Book

Springer

£113.78 14 Apr 2026
Endocrine Neoplasms: 89 (Cancer Treatment and Research, 89)
92% match

Endocrine Neoplasms: 89 (Cancer Treatment and Research, 89)

Springer

£243.50 12 Jan 2026
Endocrine Neoplasms: 89 (Cancer Treatment and Research, 89)
92% match

Endocrine Neoplasms: 89 (Cancer Treatment and Research, 89)

Springer

£211.51 11 Jan 2026
Hormones and the Endocrine System: Textbook of Endocrinology
91% match

Hormones and the Endocrine System: Textbook of Endocrinology

Springer

£92.06 12 Jan 2026
Diagnosis and Management of Endocrine-related Tumors: 20 (Cancer Treatment and Research, 20)
91% match

Diagnosis and Management of Endocrine-related Tumors: 20 (Cancer Treatment and Research, 20)

Springer

£154.99 12 Jan 2026
Phytochemicals Targeting Tumor Microenvironment in Gastrointestinal Cancers
91% match

Phytochemicals Targeting Tumor Microenvironment in Gastrointestinal Cancers

Springer

£107.25 11 Jan 2026
Endocrine Neoplasia: 153 (Cancer Treatment and Research, 153)
91% match

Endocrine Neoplasia: 153 (Cancer Treatment and Research, 153)

Springer

£79.93 22 Feb 2026
Small Molecules in Oncology: 184 (Recent Results in Cancer Research, 184)
91% match

Small Molecules in Oncology: 184 (Recent Results in Cancer Research, 184)

Springer

£139.09 19 Apr 2026
Orphan G Protein-Coupled Receptors and Novel Neuropeptides: 46 (Results and Problems in Cell Differentiation, 46)
91% match

Orphan G Protein-Coupled Receptors and Novel Neuropeptides: 46 (Results and Problems in Cell Differentiation, 46)

Springer

£106.22 07 Jan 2026
Antitumoral Properties of Natural Products
91% match

Antitumoral Properties of Natural Products

MDPI AG

£49.25 12 Feb 2026
Combination Cancer Therapy: Modulators and Potentiators (Cancer Drug Discovery and Development)
91% match

Combination Cancer Therapy: Modulators and Potentiators (Cancer Drug Discovery and Development)

Humana

£80.09 28 Feb 2026
Regulatory Peptides and Cognate Receptors: 26 (Results and Problems in Cell Differentiation, 26)
91% match

Regulatory Peptides and Cognate Receptors: 26 (Results and Problems in Cell Differentiation, 26)

Springer

£144.84 12 Jan 2026
Advances in Cancer Treatment: From Systemic Chemotherapy to Targeted Therapy
91% match

Advances in Cancer Treatment: From Systemic Chemotherapy to Targeted Therapy

Springer

£54.12 08 Mar 2026
New Trends in the Molecular and Biological Basis for Clinical Oncology
91% match

New Trends in the Molecular and Biological Basis for Clinical Oncology

Springer

£77.87 28 Feb 2026
Regulatory Peptides and Cognate Receptors: 26 (Results and Problems in Cell Differentiation, 26)
91% match

Regulatory Peptides and Cognate Receptors: 26 (Results and Problems in Cell Differentiation, 26)

Springer

£36.00 11 Jan 2026
Orphan G Protein-Coupled Receptors and Novel Neuropeptides: 46 (Results and Problems in Cell Differentiation, 46)
91% match

Orphan G Protein-Coupled Receptors and Novel Neuropeptides: 46 (Results and Problems in Cell Differentiation, 46)

Springer

£146.56 10 Mar 2026
Endocrine Therapy of Breast Cancer V (ESO Monographs)
91% match

Endocrine Therapy of Breast Cancer V (ESO Monographs)

Springer

£77.78 05 Mar 2026
Pheochromocytoma (PHEO) and Paraganglioma (PGL)
91% match

Pheochromocytoma (PHEO) and Paraganglioma (PGL)

MDPI AG

£59.67 13 Feb 2026
Genes, Oncogenes, and Hormones: Advances in Cellular and Molecular Biology of Breast Cancer: 61 (Cancer Treatment and Research, 61)
91% match

Genes, Oncogenes, and Hormones: Advances in Cellular and Molecular Biology of Breast Cancer: 61 (Cancer Treatment and Research, 61)

Springer

£201.60 11 Jan 2026